Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies
Private Anti-MOG Antibodies testing in London for £99, detecting one neurological autoimmune marker with results expected in around 3 weeks.
Turnaround time
3 weeks
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies Test
The Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies blood test detects antibodies directed against myelin oligodendrocyte glycoprotein, commonly known as MOG.
The test assesses 1 specialist neurological autoimmune marker: Anti-MOG Myelin Oligodendrocyte Glycoprotein] Antibodies.
MOG is a protein located on the outer surface of myelin in the central nervous system.
Myelin forms an insulating layer around nerve fibres within the brain, spinal cord and optic nerves.
In MOG antibody-associated disease, or MOGAD, the immune system produces antibodies recognising MOG.
This can be associated with inflammatory demyelination affecting different areas of the central nervous system.
Clinical presentations can include optic neuritis, transverse myelitis, acute disseminated encephalomyelitis and other inflammatory neurological syndromes.
MOGAD is considered distinct from conventional multiple sclerosis.
It is also distinct from aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
This distinction matters because the patterns of disease, relapse risk and treatment approach can differ.
Serum testing using an appropriate cell-based assay is commonly used to identify clinically relevant MOG antibodies.
A positive result should only be interpreted in somebody with a compatible neurological syndrome.
Low-level positive results can occasionally be less specific when testing is performed without an appropriate clinical indication.
Likewise, a negative result does not exclude every inflammatory demyelinating disorder.
MRI findings, cerebrospinal-fluid investigations, Aquaporin 4 Antibodies and neurological examination can all provide important complementary information.
What Does the Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies Test Check?
The test detects antibodies directed against MOG and can provide supporting evidence for MOG antibody-associated disease in the appropriate neurological setting. This test measures 1 specialist biomarker.
Anti-MOG Myelin Oligodendrocyte Glycoprotein] Antibodies
Detects antibodies directed against myelin oligodendrocyte glycoprotein, supporting specialist assessment of MOG antibody-associated inflammatory demyelinating disease.
Who May Benefit From the Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies Test?
Anti-MOG testing is most appropriate when symptoms, MRI findings or specialist assessment suggest an inflammatory demyelinating disorder.
People with optic neuritis - Inflammation affecting the optic nerve is one of the recognised presentations of MOGAD.
People with transverse myelitis - Spinal-cord inflammation can occur in MOG antibody-associated disease.
Children or adults with acute disseminated encephalomyelitis - MOG antibodies can be particularly relevant in selected ADEM presentations.
People with inflammatory neurological symptoms that do not fit typical multiple sclerosis - Anti-MOG testing can help distinguish different demyelinating conditions.
People with negative Aquaporin 4 Antibodies but suspected NMOSD-like disease - MOG testing can provide important additional information.
People with recurrent optic neuritis - Repeated episodes can prompt specialist autoimmune neurological investigation.
People with compatible MRI findings - Imaging patterns can guide the decision to request MOG antibody testing.
People specifically referred by a neurologist - Anti-MOG interpretation is strongest where the clinical syndrome has been established by specialist assessment.
How to Prepare
Do not stop neurological treatment simply to alter the antibody result.
The timing of testing in relation to an acute attack and immune treatment can affect interpretation and should be considered by the specialist managing the investigation.
Symptoms and Reasons to Consider the Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies Test
brain, producing symptoms according to the area of inflammation.
Sudden or subacute vision loss - Optic neuritis can reduce vision and is a common MOGAD presentation.
Eye pain associated with visual change - Pain, particularly with eye movement, can accompany optic neuritis.
Limb weakness or numbness - Spinal-cord inflammation can affect movement and sensation.
Changes in bladder or bowel function with neurological symptoms - Transverse myelitis can affect autonomic pathways.
Balance or coordination problems - Brain or spinal inflammatory lesions can affect coordination.
Episodes of neurological symptoms followed by partial recovery - Relapsing inflammatory disease can produce recurrent neurological events.
Atypical MRI findings for multiple sclerosis - MOG antibody testing may help refine the differential diagnosis.
A previous negative Aquaporin 4 Antibody test - Anti-MOG can provide complementary information where inflammatory demyelination remains suspected.
Sudden vision loss, rapidly developing limb weakness, severe sensory changes or acute neurological deterioration requires urgent clinical assessment.
Anti-MOG testing supports specialist diagnosis but does not replace neurological examination, MRI or other investigations.
A positive antibody result should be interpreted only in the context of a compatible neurological syndrome.
How to Book Your Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies Test
The Anti-MOG Antibodies test can be booked privately for specialist investigation of MOG-associated neurological autoimmunity.
Choose the Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies
Select the individual Anti-MOG blood test online.
Select your sample collection option
Choose an in-clinic blood draw or professional home or hotel phlebotomy where clinically appropriate.
Attend your appointment
A trained healthcare professional collects the required venous blood sample.
Laboratory analysis
Your serum undergoes specialist testing for Anti-MOG Myelin Oligodendrocyte Glycoprotein] Antibodies.
Receive your results securely
Your authorised result is delivered securely and should be interpreted alongside neurological symptoms, MRI and other relevant autoimmune tests.
When Will I Receive My Results?
The current live London Blood Tests page lists a turnaround of approximately 3 weeks after laboratory receipt for Anti-MOG Antibodies.
This is a specialist neurological autoantibody assay.
The specimen undergoes dedicated laboratory analysis, quality-control procedures and result authorisation.
Turnaround begins when the sample reaches the laboratory rather than necessarily from the exact time of blood collection.
Specialist repeat or confirmatory analysis can occasionally extend the expected reporting time.
Understanding Your Results
A positive Anti-MOG result means antibodies directed against myelin oligodendrocyte glycoprotein have been detected.
In somebody with a compatible clinical syndrome, this can provide important evidence supporting MOG antibody-associated disease.
The strength or titre of positivity can be relevant depending on the assay.
A positive result without a compatible neurological syndrome should be interpreted cautiously.
A negative result means MOG antibodies were not detected above the assay threshold in that sample.
This makes MOGAD less likely but does not exclude every inflammatory demyelinating condition.
Timing can matter.
Antibody concentrations can change following an acute episode or after immunotherapy.
Neurological diagnosis therefore relies on the combination of clinical symptoms, examination, MRI findings and appropriate laboratory investigations.
Aquaporin 4 Antibodies may be particularly useful where neuromyelitis optica spectrum disorder is being considered.
Why Book With London Blood Tests?
London Blood Tests provides private access to specialist Anti-MOG antibody analysis for inflammatory neurological investigation.
Measures MOG-directed antibodies - The test assesses the specialist Anti-MOG Myelin Oligodendrocyte Glycoprotein] Antibodies biomarker.
Relevant to MOGAD investigation - The antibody can provide important diagnostic support where a compatible syndrome is present.
Useful in optic neuritis assessment - Optic nerve inflammation is a recognised MOGAD presentation.
Can complement Aquaporin 4 testing - AQP4 and MOG antibodies help distinguish different inflammatory demyelinating conditions.
Useful where MS findings are atypical - Anti-MOG testing can contribute to neurological differential diagnosis.
Specialist laboratory analysis - Samples undergo dedicated neurological autoantibody testing.
Professional blood collection - Clinic and suitable home or hotel phlebotomy appointments are available.
Clear pricing - The Anti-MOG Antibodies test costs £99.
Private Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies Blood Test in London
London Blood Tests provides private Anti-MOG Antibodies testing for people requiring specialist investigation of inflammatory demyelinating disease.
The test costs £99 and assesses 1 specialist biomarker.
Results are expected approximately 3 weeks after laboratory receipt.
A positive result can support MOG antibody-associated disease but must be interpreted alongside the neurological syndrome, MRI findings and specialist assessment.